HMGB1 as a potential biomarker and therapeutic target for severe COVID-19

COVID-19 has attracted global attention due to its rapid spread around the world with substantial morbidity and associated mortality. Severe COVID-19 can be complicated by the acute respiratory distress syndrome, sepsis and septic shock leading to death. These complications are thought to result fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ruochan, Huang, Yan, Quan, Jun, Liu, Jiao, Wang, Haichao, Billiar, Timothy R., Lotze, Michael T., Zeh, Herbert J., Kang, Rui, Tang, Daolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720697/
https://www.ncbi.nlm.nih.gov/pubmed/33313438
http://dx.doi.org/10.1016/j.heliyon.2020.e05672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720697/
https://www.ncbi.nlm.nih.gov/pubmed/33313438
http://dx.doi.org/10.1016/j.heliyon.2020.e05672

Ejemplares similares